M. Cecilia Di Pentima to Anti-Bacterial Agents
This is a "connection" page, showing publications M. Cecilia Di Pentima has written about Anti-Bacterial Agents.
Connection Strength
2.171
-
Willis ZI, Duggan EM, Gillon J, Blakely ML, Di Pentima MC. Improvements in Antimicrobial Prescribing and Outcomes in Pediatric Complicated Appendicitis. Pediatr Infect Dis J. 2018 05; 37(5):429-435.
Score: 0.391
-
Gillon J, Xu M, Slaughter J, Di Pentima MC. Vancomycin Use: Room for Improvement Among Hospitalized Children. J Pharm Pract. 2017 Jun; 30(3):296-299.
Score: 0.339
-
Rose L, Coulter MM, Chan S, Hossain J, Di Pentima MC. The quest for the best metric of antibiotic use and its correlation with the emergence of fluoroquinolone resistance in children. Pediatr Infect Dis J. 2014 Jun; 33(6):e158-61.
Score: 0.298
-
Gillon JE, Cassat JE, Di Pentima MC. Validation of two vancomycin nomograms in patients 10 years of age and older. J Clin Pharmacol. 2014 Jan; 54(1):35-8.
Score: 0.287
-
Rose L, Chan S, Hossain J, Di Pentima MC. Effects of aggregate and individual antibiotic exposure on vancomycin MICs for Staphylococcus aureus isolates recovered from pediatric patients. J Clin Microbiol. 2013 Sep; 51(9):2837-42.
Score: 0.279
-
Cies JJ, Chan S, Hossain J, Brenn BR, Di Pentima MC. Influence of body mass index and antibiotic dose on the risk of surgical site infections in pediatric clean orthopedic surgery. Surg Infect (Larchmt). 2012 Dec; 13(6):371-6.
Score: 0.269
-
Di Pentima MC, Chan S. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J. 2010 Aug; 29(8):707-11.
Score: 0.228
-
Ros? L, Coulter MM, Chan S, Hossain J, Di Pentima MC. Trends of fluoroquinolone-resistant Escherichia coli amongst urinary isolates in children: a 10 year surveillance study. J Med Microbiol. 2015 Jul; 64(7):778-781.
Score: 0.080